Skip to main content
. 2012 Aug 8;10:23. doi: 10.1186/1478-811X-10-23

Table 2.

Expression of cell cycle genes during the development of PCMOs cultured in the presence of HB-EGF or EGF

  ABL ANAPC2 CDC2 CDK4 CDK6
Hb-EGF 10
 1.40 ± 0.19a
 1.74 ± 0.62
 1.88 ± 0.74
 1.53 ± 0.33
 2.42 ± 1.10
Hb-EGF 50
 1.26 ± 0.15a
 1.40 ± 0.45
 1.81 ± 0.77
 1.56 ± 0.33
 2.09 ± 0.80
Hb-EGF 100
 1.48 ± 0.43
 1.63 ± 0.66
 2.23 ± 0.95
 1.47 ± 0.27
 2.35 ± 1.06
EGF 10
 2.24 ± 0.18ab
 1.78 ± 0.43
 3.01 ± 1.05ab
 1.57 ± 0.17
 2.47 ± 0.96
EGF 50
 1.69 ± 0.20ab
 1.70 ± 0.42
 1.99 ± 0.42a
 1.39 ± 0.10
 2.15 ± 0.87
EGF 100
 1.74 ± 0.30ab
 1.60 ± 0.38
 2.02 ± 0.50a
 1.53 ± 0.14
 2.38 ± 0.93
ANOVA = 0.0033 0.0748 0.036 0.261 0.0756